These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7636679)

  • 1. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions.
    Hofmann AF
    J Pediatr Gastroenterol Nutr; 1995 May; 20(4):376-90. PubMed ID: 7636679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestasis of total parenteral nutrition: bile acid and bile lipid metabolism in parenterally nourished rats.
    Lirussi F; Vaja S; Murphy GM; Dowling RH
    Gastroenterology; 1989 Feb; 96(2 Pt 1):493-502. PubMed ID: 2492012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets.
    Duerksen DR; Van Aerde JE; Gramlich L; Meddings JB; Chan G; Thomson AB; Clandinin MT
    Gastroenterology; 1996 Oct; 111(4):1111-7. PubMed ID: 8831607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary lipid composition and bile acid profiles during and after enteral fast of total parenteral nutrition in the rabbit.
    Das JB; Poulos ND; Ansari GG
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):85-91. PubMed ID: 8788293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
    Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of taurine on total parenteral nutrition-associated cholestasis.
    Guertin F; Roy CC; Lepage G; Perea A; Giguère R; Yousef I; Tuchweber B
    JPEN J Parenter Enteral Nutr; 1991; 15(3):247-51. PubMed ID: 1907674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K; Hohenester S; Winkler-Budenhofer U; Bastiaansen BA; Schaap FG; Rust C; Beuers U
    J Hepatol; 2012 Jul; 57(1):133-40. PubMed ID: 22414767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
    Spagnuolo MI; Iorio R; Vegnente A; Guarino A
    Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine prevents total parenteral nutrition (TPN)-induced cholestasis without changes in hepatic oxidative stress in the rat.
    Belli DC; Albrecht R; La Scala GC; Desjeux JF; Pelissier MA
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):200-5. PubMed ID: 12548054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early hepatobiliary dysfunction during total parenteral nutrition: an experimental study.
    Das JB; Cosentino CM; Levy MF; Ansari GG; Raffensperger JG
    J Pediatr Surg; 1993 Jan; 28(1):14-8. PubMed ID: 8429464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing enterocolitis and total parenteral nutrition-associated cholestasis.
    Moss RL; Das JB; Raffensperger JG
    Nutrition; 1996 May; 12(5):340-3. PubMed ID: 8875518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.
    Jain AK; Stoll B; Burrin DG; Holst JJ; Moore DD
    Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(2):G218-24. PubMed ID: 22094603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
    Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF
    Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
    Arslanoglu S; Moro GE; Tauschel HD; Boehm G
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
    Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
    Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary lithocholate and cholestasis during and after total parenteral nutrition: an experimental study.
    Das JB; Uzoaru IL; Ansari GG
    Proc Soc Exp Biol Med; 1995 Dec; 210(3):253-9. PubMed ID: 8539263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants.
    Simić D; Milojević I; Bogićević D; Milenović M; Radlović V; Drasković B; Benka AU; Sindjić S; Maksimović R
    Srp Arh Celok Lek; 2014; 142(3-4):184-8. PubMed ID: 24839773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids as drugs: principles, mechanisms of action and formulations.
    Hofmann AF
    Ital J Gastroenterol; 1995 Mar; 27(2):106-13. PubMed ID: 7579591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver complications of pediatric parenteral nutrition--epidemiology.
    Kelly DA
    Nutrition; 1998 Jan; 14(1):153-7. PubMed ID: 9437702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.